Latest Headlines

Latest Headlines

Glaxo's Ebola vaccine trial set to begin in September

As the Ebola outbreak continues to claim victims in West Africa, governments and industry alike are racing toward a therapeutic or preventive drug that could help halt its deadly spread and avert future human crises involving the virus.

Passive vaccine could treat cocaine overdose

Scripps Research Institute is developing a passive vaccine to treat cocaine overdose and has seen promising results in animals.

DepoVax drug and vaccine combination cuts tumor immunosuppression

Part of the success of some cancers is that they can avoid an immune response, and this can also cut the response to vaccines. Immunovaccine is developing a comeback to this--suppress the suppression.

Immunovaccine to focus on ovarian cancer

Halifax, Nova Scotia-based Immunovaccine will focus the Phase I/II clinical development plan for DPX-Survivac on ovarian cancer. The decision is based on positive input from leaders in cancer